多西紫杉醇
医学
紫杉醇
内科学
白蛋白
肿瘤科
药理学
化疗
作者
Yasuto Yoneshima,Satoshi Morita,Masahiko Ando,Atsushi Nakamura,Shunichiro Iwasawa,Hiroshige Yoshioka,Yasuhiro Gotô,Masafumi Takeshita,Toshiyuki Harada,Katsuya Hirano,Tetsuya Oguri,Masashi Kondo,Satoru Miura,Yukio Hosomi,Terufumi Kato,Toshio Kubo,Junji Kishimoto,Nobuyuki Yamamoto,Yoichi Nakanishi,Isamu Okamoto
标识
DOI：10.1016/j.jtho.2021.03.027
摘要
Nab-paclitaxel was noninferior to docetaxel in terms of OS. It should, thus, be considered a standard treatment option for previously treated patients with advanced NSCLC.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
皖公网安备34019202002308
